US government has altered more than 100 scientific databases since 20 January
5 July 2025. Related: Early access, Treatment alerts, Activism & advocacy.
2025
Latest news on US crisis (3 July): legal challenges, Global Fund, WHO, Kigali conference
5 July 2025. Related: Treatment access, Activism & advocacy.
13th IAS Conference on HIV Science (IAS 2025)
3 July 2025. Related: Conference reports, Activism & advocacy.
Clinical phase 2/3 studies put on hold for two once-weekly pipeline compounds
3 July 2025. Related: Antiretrovirals.
UK PrEP 2025 guidelines: reviewed online
2 July 2025. Related: Guidelines, HIV prevention and transmission.
Why the new HIV PrEP guidelines from the UK are so exciting (2025)
2 July 2025. Related: Special reports, Guidelines, HIV prevention and transmission.
Latest on US crisis (26 June): Global Fund, GAVI and RFK Jr
2 July 2025. Related: Treatment alerts, Activism & advocacy.
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
1 July 2025. Related: Antiretrovirals, HIV prevention and transmission.
Future meetings and webinars 2025
1 July 2025. Related: Future meetings.
Latest on US crisis (13 June): legal and organisational responses
1 July 2025. Related: Treatment alerts, Activism & advocacy.
HIV organisations support trans and non-binary communities against the unworkable EHRC guidance
1 July 2025. Related: Treatment access, Activism & advocacy.
Featured UK HIV care for transgender and non-binary people: EHRC guidance is unworkable
1 July 2025. Related: Special reports, Treatment access, Activism & advocacy.
Kigali Call to Action: sign-on for IAS 2025 conference
1 July 2025. Related: Conference reports.
UK guidelines on doxyPEP to prevent syphilis and gonorrhoea vaccine to become available in England
17 June 2025. Related: Guidelines, Coinfections and complications.
APBI calls for greater participant diversity in industry studies
15 June 2025. Related: Activism & advocacy, Research studies.
Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir
7 June 2025. Related: Journal scan, Side effects, Weight, diabetes, metabolic complications.
TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel
6 June 2025. Related: Treatment access, Activism & advocacy, Research studies.
Gates Foundation commits to providing lenacapavir as PrEP next year
3 June 2025. Related: Treatment access, HIV prevention and transmission.
Featured Latest news on the US crisis and its impact on global health
1 June 2025. Related: Journal scan, Special reports, Treatment access, Activism & advocacy.
IAS-USA update drug resistance mutations (2025)
29 May 2025. Related: Guidelines, Drug resistance.
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025. Related: Journal scan, mpox.
US updates guidelines for statin use in people living with HIV
26 May 2025. Related: Guidelines, Weight, diabetes, metabolic complications.
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet
26 May 2025. Related: Journal scan, Treatment access, Activism & advocacy.
Combining injectable lenacapavir and cabotegravir-LA
23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025. Related: Treatment access, Activism & advocacy, Research studies.
Impact of US funding cuts in Malawi and South Africa: ITPC community report
20 May 2025. Related: Treatment access, On the web.
The Denver Principles – riso print by Jane Shepherd to support i-Base
17 May 2025. Related: Special reports.
US CDC updated guidelines on PEP (May 2025)
10 May 2025. Related: Guidelines, HIV prevention and transmission.
Featured Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025. Related: Special reports, Antiretrovirals, Treatment strategies, Treatment access.
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025. Related: Treatment access, Activism & advocacy.
Yellow card reporting scheme for doctors and patients in the UK
1 May 2025. Related: Side effects.
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025. Related: Conference reports, Cure-related research.
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025. Related: Antiretrovirals, Treatment access, Drug resistance, BHIVA news.
CROI 2025: Webcasts and other resources now open access
16 April 2025. Related: Conference reports.
Continued reports from CROI 2025
13 April 2025. Related: Conference reports.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025. Related: Journal scan, Treatment strategies, Drug resistance.
CROI 2025: LAPTOP, EC rebounds after 32 years, two more HSCT cures
12 April 2025. Related: Conference reports, Antiretrovirals, Treatment strategies.
Lancet Commission on gender justice and equality
9 April 2025. Related: Journal scan.
Changes to US policy jeopardises the lives of 500,000 children living with HIV by 2030
8 April 2025. Related: Treatment access.
CROI 2025: Rebecca Denison gives opening community talk on 40 years of HIV
7 April 2025. Related: Conference reports, Activism & advocacy.
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025. Related: Journal scan, Special reports, Treatment access.
CROI 2025: BHIVA best of CROI feedback now online
1 April 2025. Related: Conference reports, On the web.
People living with HIV need two shots of the mpox vaccine and likely a booster after two years
1 April 2025. Related: Journal scan, mpox.
CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort
1 April 2025. Related: Conference reports, Cure-related research.
Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030
28 March 2025. Related: Journal scan, Treatment access.
Stopping ART safely if your clinic is closed or runs out of meds: a practical guide
25 March 2025. Related: Special reports, Treatment strategies.
Webinar on stopping ART if your clinic is closed: practical facts on safety and risk
24 March 2025. Related: Special reports, Treatment strategies, Treatment access, On the web.
CROI 2025: Introduction to this year’s conference
22 March 2025. Related: Conference reports.
CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission
21 March 2025. Related: Conference reports, Cure-related research.
CROI 2025: Switching to daily fixed-dose doravirine/islatravir: two randomised phase 3 studies
20 March 2025. Related: Conference reports, Antiretrovirals.
CROI 2025: Tecovirimat has no benefit against mpox in STOMP study
18 March 2025. Related: Conference reports, mpox.
CROI 2025: Ensitrelvir significantly reduces risk of developing COVID-19 after household exposure
18 March 2025. Related: Conference reports, COVID-19.
CROI 2025: N6LS: 4-monthly injectable bNAb with monthly injectable cabotegravir
18 March 2025. Related: Conference reports, Antiretrovirals.
Summary of Australian guidelines for anal cancer screening in people living with HIV
18 March 2025. Related: Guidelines.
CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week
17 March 2025. Related: Conference reports, Antiretrovirals, Treatment strategies.
CROI 2025: Potential for once-yearly lenacapavir injections
16 March 2025. Related: Conference reports, Antiretrovirals, PK and drug interactions, HIV prevention and transmission.
CROI 2025: Delegates send open letter to protest US cuts
12 March 2025. Related: Conference reports, Activism & advocacy.
CROI 2025: Stand Up For Science rally against Trump funding freeze
9 March 2025. Related: Conference reports, Activism & advocacy.
HIV and vaccine denialist is proposed to head the US NIH: further alarm for global science
7 March 2025. Related: Activism & advocacy.
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025. Related: Special reports, Treatment access.
Responses to the UK government slashing international aid by 40%
26 February 2025. Related: Treatment access, Activism & advocacy.
Deleted words from official documents: LGBTQ, diversity, inclusion, transgender
26 February 2025. Related: Treatment access, Activism & advocacy.
Country update from Nigeria: current impact on HIV services
22 February 2025. Related: Special reports, Treatment access.
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
12 February 2025. Related: Weight, diabetes, metabolic complications, Coinfections and complications.
News and resources linked to changes in US policy on international aid
7 February 2025. Related: Special reports.